Unlock instant, AI-driven research and patent intelligence for your innovation.

Glucosamine modified RGD oligopeptides derivative, preparation method and application thereof

An amino acid and amino acid-based technology, applied in the direction of peptides, tetrapeptide components, drug combinations, etc., can solve the problems of small adverse reactions and obvious side effects

Inactive Publication Date: 2014-04-09
CAPITAL UNIVERSITY OF MEDICAL SCIENCES
View PDF1 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Now more commonly used non-steroidal anti-inflammatory drugs have their own anti-inflammatory or antipyretic and analgesic characteristics, and most of them alleviate the adverse reactions to a certain extent, but their side effects are still obvious, especially the toxicity of the gastrointestinal tract People hope to develop anti-inflammatory drugs with less adverse reactions

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Glucosamine modified RGD oligopeptides derivative, preparation method and application thereof
  • Glucosamine modified RGD oligopeptides derivative, preparation method and application thereof
  • Glucosamine modified RGD oligopeptides derivative, preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

preparation example 1

[0072] Preparation Example 1 Arg(NO 2 ) preparation

[0073] In an ice-salt bath, concentrated nitric acid (6 mL) and concentrated sulfuric acid (6 mL) were added to a 100 ml eggplant bottle, and arginine (Arg) (3.55 g, 20.38 mmol) was added in batches to the above mixture, and the reaction was carried out for about 2 h. Add ice water (7mL) dropwise to the reaction mixture, slowly adjust the pH to 8 with concentrated ammonia water, then adjust the pH to 6 with acetic acid, a large amount of white solid precipitates, filter, and mix dichloromethane and methanol at 80°C The solvent recrystallized the colorless solid to give the title compound (2.98 g, 13.60 mmol) as a colorless solid. Yield 67%.

preparation example 2Bo

[0074] Preparation example 2Boc-Arg (NO 2 ) preparation

[0075] Add R(NO 2 ) (2.18g, 9.95mmol), then add water (20mL), adjust the pH to 9 with 2N NaOH under ice cooling, the mixture is still white and turbid. Di-tert-butyl dicarbonate (Boc 2 O) (2.48g, 11.38mmol), reacted at room temperature, adjusted the pH of the reaction mixture to 9, the mixed solution gradually became clear, TLC (thin layer chromatography) monitored the reaction was complete for about 48h. The reaction solution was concentrated to dryness under reduced pressure, a small amount of water (50 mL) was added to the residue, and the pH was adjusted to 2 with saturated potassium bisulfate, extracted with ethyl acetate (40 mL×3), and the organic layer was washed with saturated sodium chloride (20 mL× 3), dried over anhydrous sodium sulfate, filtered, and the filtrate was concentrated to dryness under reduced pressure to obtain the target compound (2.53 g, 7.90 mmol) as a colorless solid with a yield of 79%. ...

preparation example 3To

[0076] Preparation Example 3 Preparation of Tos Gly-OBzl

[0077] Add glycine (Gly) (3.75g, 50.00mmol), benzyl alcohol (60mL, 600mmol), p-toluenesulfonic acid (11.40g, 60mmol) and cyclohexane (60mL) into a 250ml eggplant bottle. The reaction was carried out at 100°C in an oil bath, and the reaction was completed in about 60 hours as monitored by TLC. The reactant was cooled to room temperature, a large amount of diethyl ether (150 mL) was added, and the target compound (16.5 g, 49.0 mmol) was obtained by filtration as a colorless solid. Yield 98%.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a glucosamine modified RGD oligopeptides derivative, a preparation method and an application. Concretely, the invention relates to the glucosamine modified RGD oligopeptides derivative in a general formula (I) and its pharmaceutically acceptable salt, wherein R1 is selected from hydrogen, benzyl, benzoyl or C1-C10 alkanoyl groups, and AA and n is defined as an instruction. The invention also relates to the preparation method of the compound in the general formula (I), and the application of a pharmaceutical composition containing the compound in the general formula (1) and the above compound for preparing the anti-inflammatory medicines.

Description

technical field [0001] The invention relates to a glucosamine-modified RGD oligopeptide derivative and a preparation method thereof, a pharmaceutical composition containing the compound and an application of the compound in the preparation of anti-inflammatory drugs. Background technique [0002] There are two types of anti-inflammatory drugs: one is steroidal anti-inflammatory drugs, that is, the glucocorticoid hydrocortisone secreted by the adrenal cortex and its synthetic derivatives. The other is non-steroidal anti-inflammatory drugs such as aspirin and phenylbutazone. [0003] The chemical essence of steroidal anti-inflammatory drugs is natural or synthetic glucocorticoids. In 1949, Hench et al first used cortisone to treat arthritis, rheumatism, etc. Although it was found that it had a strong anti-inflammatory effect, its side effects were serious, especially when it was applied in large doses, not only could it cause dependence, but it could also cause adrenal cortex...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07K5/11A61K38/07A61P29/00
Inventor 张建伟王晓民徐贵超李虹
Owner CAPITAL UNIVERSITY OF MEDICAL SCIENCES